Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension

Julie J. Lewandowski-Belfer, Alden V. Patel, Robert M. Darracott, Daniel A. Jackson, Jerah D. Nordeen, W. David Freeman

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences